C
Complete Omics
Biotech & Life Sciences · Arbutus, United States · Founded 2019
Innovative molecular diagnostics and OMICs technologies for cancer proteomics and genomics MoreLess
Complete Omics Inc. is a pioneering company in the field of molecular diagnostics, focusing on the detection and quantification of biomarkers for personalized cancer treatment. Founded by Dr. Qing Wang and a team of expert scientists, the company leverages advanced technologies like Mass Spectrometry and Next Generation Sequencing (NGS) to identify mutant proteins specific to cancer. This allows for highly personalized and precise cancer therapies.
The company operates in the healthcare and biotechnology market, serving a diverse range of clients including hospitals, research institutions, and pharmaceutical companies. Complete Omics specializes in multi-omics platforms, which means they analyze various biological data types such as genomics, proteomics, and metabolomics to provide comprehensive insights into an individual's health.
Complete Omics' business model revolves around offering specialized diagnostic services and products. They have developed a series of optimized sample processing and purification procedures that significantly enhance the sensitivity and accuracy of their tests. Their flagship service, the Complete Clinical Proteomics pipeline, is designed to be the most sensitive and specific tool for clinical proteomics, aiding in the development of personalized cancer therapeutics.
Revenue is generated through service contracts with healthcare providers and research institutions, as well as through the sale of diagnostic kits and software solutions. The company also collaborates with pharmaceutical firms to develop targeted cancer therapies, providing another revenue stream.
In summary, Complete Omics is at the forefront of personalized medicine, using cutting-edge technology to improve cancer diagnosis and treatment. Their commitment to innovation and precision makes them a valuable player in the healthcare industry.
Keywords: molecular diagnostics, cancer biomarkers, personalized medicine, Mass Spectrometry, Next Generation Sequencing, proteomics, metabolomics, healthcare, biotechnology, cancer therapy.
Company overview
Complete Omics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Arbutus, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 83.8
Valuation & funding
Complete Omics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Nov 2023 | $10M | $40M | Qiming Venture Partners | ↗ |
| SPINOUTOther financing | Jan 2019 | — | — | Johns Hopkins University | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 14 |
| 2025 | 11 |
| 2024 | 9 |
| 2023 | 7 |
Growth signals
Complete Omics website traffic
Latest recorded traffic for Complete Omics is 1.7K monthly website visits, up 107.3% over the last three months. Complete Omics's team grew 27.3% over the past year.
Comparisons
Complete Omics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Complete Omics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Complete Omics has talent and traffic
team presence
In the news
Latest news about Complete Omics
Recent press, funding announcements, and product moves mentioning Complete Omics — open to read from the original sources.
Market sentiment
What the market is saying about Complete Omics
An AI-synthesized read of the highest-engagement posts about Complete Omics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Complete Omics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.